Title : Genetic variations in multiple myeloma II: association with effect of treatment.

Pub. Date : 2012 Feb

PMID : 21883476






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In thalidomide- and bortezomid-based therapy, candidate genes include TNFA and genes involved in the nuclear factor kappa B pathway (NFKB2 and TRAF3), respectively. Thalidomide tumor necrosis factor Homo sapiens